{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1571135650755282944.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"NAID","@value":"10030965950"}}],"dc:title":[{"@language":"en","@value":"Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS) : a randomised phase 3 trial"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1581135650755282944","@type":"Researcher","foaf:name":[{"@language":"en","@value":"RINI BI"}]}],"publication":{"prism:publicationName":[{"@language":"en","@value":"Lancet"}],"prism:publicationDate":"2011","prism:volume":"378","prism:startingPage":"1931","prism:endingPage":"1939"},"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1520290883587412864","@type":"Article","relationType":["isCitedBy"],"jpcoar:relatedTitle":[{"@value":"腎細胞癌に対する分子標的薬 : 血管新生阻害薬"},{"@language":"ja-Kana","@value":"ジンサイボウガン ニ タイスル ブンシ ヒョウテキヤク : ケッカン シンセイ ソガイヤク"}]}],"dataSourceIdentifier":[{"@type":"CIA","@value":"10030965950"}]}